|
|
 |
|
Viewing report
|
|
|
|
Global Diabetes Market Report: 2011 Edition
Koncept Analytics, Oct 2011, Pages: 58
Diabetes is a group of metabolic diseases in which a person has high blood sugar which is either due to the fact that insulin produced by the body is not enough or the body does not respond to the insulin that is produced in the body.
Mainly there are three type of diabetes:
- Type 1 diabetes
- Type 2 diabetes
- Gestational diabetes
Pre-diabetes is a condition that occurs when blood glucose level of a person is higher than normal but not high enough so as to diagnose for type 2 diabetes. Depending upon the speed at which the injected insulin is absorbed by the body, different types of insulin devices are available in the market.
Diabetic population has been continuously increasing over the years. There are several factors responsible for increase in diabetic population such as family history, obesity, smoking, alcohol, hypertension, etc.
Ageing population and obesity are among the key drivers of diabetes market. Due to rising aging population, the probability of prevalence of chronic disease also increases which is a major cause of more and more people having diabetes. Urbanization leading to modern lifestyle also deeply influences the health of the people, thereby increasing the diabetic population.
Europe has the largest diabetic population and the largest insulin market followed by North America. Diabetes prevalence rate is high in the US and China. Novo Nordisk, Takeda, Sanofi-Aventis, Eli Lilly, Merck and GSK are among the largest players in diabetes market.
Key Features:
The report analyzes the global diabetes market including the US, Europe, Africa, South and Central America, South and Asia-Pacific. Key issues like lack of sufficient diagnosis and treatment facilities, cost and effective management have also been included in this report. The competition prevailing in the diabetes market has been analyzed with focus on global and regional market share of major players in diabetes and insulin market. The report also profiles the major players in the market.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, thre report forecasts the future growth of the global diabetic population. Various significant variables that have an impact on this industry and created regression models with SPSS Base have been used to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
|
|
|
|
